- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on King Pharmaceuticals Inc. (KG)
by latest | most commented
-
FDA Calendar Updates: King Pharma, Pain Therapeutics
-
FDA Calendar Updates: Novo Nordisk, Eisai, Acura, King and Myriad Pharma
-
Generic Players Continue to Impress in H1
-
King Pharma's June Results: A Look Ahead
-
FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS
-
Pending FDA Decisions: 20 Extreme Trades
-
FDA Calendar: 18 Hot Summer Trades
-
30 Attractive Companies Under $30: Fidelity's Low Priced Stock Fund Part II
-
Parsing King Pharma's Q1
-
FDA Calendar Updates: Royal Returns for King Pharma
-
Wall Street Breakfast: Must-Know News
-
FDA, Clinical Trial Calendars: Nine 'Cash Plus Catalyst' Trades
-
Beware 'Cheap' Stocks
-
Wednesday Options Recap
-
Evaluating Biggest and Smallest Stocks Per Sector
-
King Pharma: Value Play on New Drug Approvals
-
The Argus Screen for Cash-Rich Companies
-
Wall Street Breakfast: Must-Know News
-
Fairfax Financial's Holdings Reveal Increased Faith in Equities
-
FDA Decision Calendar: Pain Drug Delays Likely
-
The Chutes and Ladders Market
-
Companies in Shape, and Looking Good...
-
Stocks Affected by FDA Calendar of Expected Decision Dates
-
Updated FDA Decision Calendar: Five Decisions Before Year-End
-
FDA Calendar Update: High Hopes for Amgen's Bone Drug
-
Updated FDA Calendar: Cypress Bioscience Looks Like a Buy
-
The Magic Formula's Top 20 Price/Book Ratio Stocks
-
Investment Ideas That Stand Out from ETF Innovators New Indexes
-
AMAG, Caraco and More: Near-Term Catalysts, Courtesy FDA
-
Ten Bright Ways to Invest in Tennessee
-
Stocks Offering 'Healthy' Returns
-
Top Ten Magic Formula Stocks with Strong Relative Strength
-
Full FDA Calendar for Remainder 2008
-
Post-Election Stock Massacre
-
S&P 500 Stocks Above 50-Day Moving Averages
-
Backlog of Decisions Is Building at the FDA
-
Wall Street Breakfast: Must-Know News
-
Earnings Preview: King Pharmaceuticals
-
23 Stocks to Consider During Global Deleveraging
-
FDA Watch: Painkillers on the Fall/Winter Agenda
-
Animal Healthcare Biz Posts Loss, But Outpaces Healthcare ETFs